Regentis Biomaterials Ltd. filed a request with the SEC on June 15, 2026, to withdraw its Registration Statement No. 333-295510 on Form F-1. The company decided not to proceed with the public offering associated with that registration statement. Regentis Biomaterials Ltd. is a biotechnology company focused on biomaterials.
